image_pdfimage_print
10 01, 2023

SB 130

An Act to amend 632.895 (16v) (a) (intro.) of the statutes; Relating to: prescription drug limits. This bill prohibits insurers that offer health insurance, self-insured governmental health plans, and pharmacy benefit managers from requiring, until June 30, 2021, prior authorization for early refills of a prescription drug or otherwise restricting the period in which a prescription drug may be refilled and from imposing a limit on the quantity of prescription drugs that may be obtained if the quantity is no more than a 90-day supply.

SB 130
10 01, 2023

AB 544 (see companion bill SB 540)

An Act to create 15.07 (3) (bm) 7., 15.735 and subchapter VI (title) of chapter 601 [precedes 601.78] of the statutes; Relating to: creating a prescription drug affordability review board and granting rule-making authority.

AB 544 (see companion bill SB 540)
10 01, 2023

SB 540 (see companion bill AB 544)

An Act to create 15.07 (3) (bm) 7., 15.735 and subchapter VI (title) of chapter 601 [precedes 601.78] of the statutes; Relating to: creating a prescription drug affordability review board and granting rule-making authority.

SB 540 (see companion bill AB 544)
10 01, 2023

SB 546 (see companion bill AB 552)

An Act relating to: eliminating cost sharing for prescription drugs under the Medical Assistance program. Under current law, certain persons who receive health services under the Medical Assistance program, also known in this state as BadgerCare, are required to contribute a cost sharing payment to the cost of certain health services. This bill eliminates all cost sharing payments for prescription drugs under the Medical Assistance program.

SB 546 (see companion bill AB 552)
10 01, 2023

SB 548 (see companion bill AB 555)

An Act to create 601.31 (1) (nv) and 632.863 of the statutes; Relating to: licensure of pharmaceutical representatives. This bill requires a pharmaceutical representative to be licensed by the Office of the Commissioner of Insurance and to display his or her license during each visit with a health care professional. The bill defines “pharmaceutical representative” to mean an individual who markets or promotes pharmaceuticals to health care professionals on behalf of a pharmaceutical manufacturer for compensation. The bill requires that a pharmaceutical representative, during each contact with a health care professional, disclose the wholesale [...]

SB 548 (see companion bill AB 555)
10 01, 2023

AB 1185

An Act to create 609.045 of the statutes; Relating to: insurance coverage and balance billing for certain health care services and granting rule-making authority.

AB 1185
10 01, 2023

AB 555 (see companion bill SB 548)

An Act to create 601.31 (1) (nv) and 632.863 of the statutes; Relating to: licensure of pharmaceutical representatives. This bill requires a pharmaceutical representative to be licensed by the Office of the Commissioner of Insurance and to display his or her license during each visit with a health care professional. The bill defines “pharmaceutical representative” to mean an individual who markets or promotes pharmaceuticals to health care professionals on behalf of a pharmaceutical manufacturer for compensation. The bill requires that a pharmaceutical representative, during each contact with a health care professional, disclose the wholesale [...]

AB 555 (see companion bill SB 548)
10 01, 2023

AB 556 (see companion bill SB 578)

An Act to create 20.145 (1) (g) 4. of the statutes; Relating to: funding for an office of prescription drug affordability, crediting certain amounts to the general program operations account of the office of the commissioner of insurance, and making an appropriation.

AB 556 (see companion bill SB 578)
15 12, 2022

Healthcare Consolidation Q4 2022: Cross-Market Mergers Continue Apace

2022 has been an active year in healthcare consolidation as well as for merger challenges and enforcement. As we approach the year end, healthcare deals continued as many entities seek to close the transactions before the new year. Increasingly, as seen in the 4th quarter, healthcare deals are shifting to cross-market transactions, making review and enforcement efforts more challenging. In case you missed it, this final Litigation and Enforcement Highlights of the year will help you catch up on some of the cross-market deals in Q4 2022 that caught our attention.   Advocate Aurora [...]

Healthcare Consolidation Q4 2022: Cross-Market Mergers Continue Apace
© Copyright 2014 -    |   The Source   |   All Rights Reserved
Go to Top